MEI Pharma Inc (MEIP):企業の財務・戦略的SWOT分析

◆英語タイトル:MEI Pharma Inc (MEIP) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH61270FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥35,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥52,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

MEI Pharma Inc (MEIP) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

MEI Pharma Inc (MEI Pharma), formerly Marshall Edwards Inc, develops drugs for the treatment of cancer. The company’s drug candidates include pracinostat, an oral histone deacetylase inhibitor, intended for the treatment of advanced hematological diseases including myelodysplastic syndrome; ME-344, a mitochondrial inhibitor intended for the treatment of HER2-negative breast cancer and solid tumors; and Zandelisib (ME-401), an oral PI3K delta inhibitor for relapsed or refractory B-cell malignancies. The company also develops and commercializes Voruciclib, an oral and selective cyclin-dependent kinase (CDK) inhibitor intented for the treatment of acute myeloid leukemia (AML) and B-cell malignancies through an agreement with Presage. MEI Pharma is headquartered in San Diego, California, the US.

MEI Pharma Inc Key Recent Developments

Apr 05,2021: MEI Pharma to present at the 20th Annual Needham Virtual Healthcare Conference
Feb 04,2021: MEI Pharma Reports Second Quarter Fiscal Year 2021 Results and Operational Highlights
Nov 10,2020: MEI Pharma reports first quarter fiscal year 2021 results and operational highlights
Sep 09,2020: MEI Pharma reports fiscal year 2020 results and operational highlights
May 07,2020: MEI Pharma reports fiscal third-quarter 2020 results and recent corporate highlights

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
MEI Pharma Inc – Key Facts
MEI Pharma Inc – Key Employees
MEI Pharma Inc – Key Employee Biographies
MEI Pharma Inc – Major Products and Services
MEI Pharma Inc – History
MEI Pharma Inc – Company Statement
MEI Pharma Inc – Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Company Overview
MEI Pharma Inc – Business Description
R&D Overview
MEI Pharma Inc – Corporate Strategy
MEI Pharma Inc – SWOT Analysis
SWOT Analysis – Overview
MEI Pharma Inc – Strengths
MEI Pharma Inc – Weaknesses
MEI Pharma Inc – Opportunities
MEI Pharma Inc – Threats
MEI Pharma Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
MEI Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
MEI Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
MEI Pharma Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 05, 2021: MEI Pharma to present at the 20th Annual Needham Virtual Healthcare Conference
Feb 04, 2021: MEI Pharma Reports Second Quarter Fiscal Year 2021 Results and Operational Highlights
Nov 10, 2020: MEI Pharma reports first quarter fiscal year 2021 results and operational highlights
Sep 09, 2020: MEI Pharma reports fiscal year 2020 results and operational highlights
May 07, 2020: MEI Pharma reports fiscal third-quarter 2020 results and recent corporate highlights
Apr 14, 2020: MEI Pharma appoints Cheryl Cohen, product launch and commercialization veteran, to its board of directors
Feb 06, 2020: MEI Pharma reports fiscal second-quarter 2020 results and operational highlights
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
MEI Pharma Inc, Key Facts
MEI Pharma Inc, Key Employees
MEI Pharma Inc, Key Employee Biographies
MEI Pharma Inc, Major Products and Services
MEI Pharma Inc, History
MEI Pharma Inc, Key Competitors
MEI Pharma Inc, Ratios based on current share price
MEI Pharma Inc, Annual Ratios
MEI Pharma Inc, Annual Ratios (Cont...1)
MEI Pharma Inc, Interim Ratios
MEI Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
MEI Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
MEI Pharma Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[MEI Pharma Inc (MEIP):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dakota Gasification Co:企業の戦略的SWOT分析
    Dakota Gasification Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Victorian WorkCover Authority:企業の戦略的SWOT分析
    Victorian WorkCover Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Medimetriks Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Medimetriks Pharmaceuticals Inc (MPI) is a drug company that offers skincare products. The company provides personal care products including cleansers, nutritional suppliments, cosmetic creams, and moisturizer. Its products include Centany, Ciclodan, Clindacin ETZ, Genadur, Ketodan, Morgidox …
  • Management Consulting Group Plc (MMC):企業の財務・戦略的SWOT分析
    Summary Management Consulting Group plc (MCG), formerly Proudfoot Consulting Plc, is a professional services consultancy firm. The company through its subsidiaries designs, implements and accelerates operational transformation for the long-term benefit of a business. It provides consultancy and mana …
  • C.A. Curtze Co. Inc.
    C.A. Curtze Co. Inc. - Strategy, SWOT and Corporate Finance Report Summary C.A. Curtze Co. Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Miromatrix Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Miromatrix Medical Inc (Miromatrix Medical) is a biotechnology company engaged in the development extracellular matrix based medical devices in soft tissue reinforcement and advanced wound care. The company offers MIRODERM a porcine liver-derived noncrosslinked acellular biologic wound matri …
  • Norwest Venture Partners XII, LP:企業のM&A・事業提携・投資動向
    Norwest Venture Partners XII, LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Norwest Venture Partners XII, LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Breakthru Beverage Group, LLC:企業の戦略・SWOT・財務分析
    Breakthru Beverage Group, LLC - Strategy, SWOT and Corporate Finance Report Summary Breakthru Beverage Group, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Deltex Medical Group Plc (DEMG):企業の財務・戦略的SWOT分析
    Summary Deltex Medical Group Plc (Deltex Medical), formerly Chalkgrove Plc, is a medical device company that develops fluid management equipment and oesophageal doppler monitoring systems. The company offers products such as cardioQ-ODM+, probes, simulator, bougies, cerebral oximetry, video laryngos …
  • Sun Hydraulics Corporation:企業の戦略・SWOT・財務情報
    Sun Hydraulics Corporation - Strategy, SWOT and Corporate Finance Report Summary Sun Hydraulics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Censo Biotechnologies Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Censo Biotechnologies Ltd (Censo) formerly Roslin Cellab Limited, a subsidiary of Roslin Foundation is a provider of human cells and contract research services for drug discovery, toxicity testing and cell banking. The company offers iPSC services; differentiated cell types; in vitro assays; …
  • AnaMar AB-製薬・医療分野:企業M&A・提携分析
    Summary AnaMar AB (AnaMar), a subsidiary of Koncentra Holding AB, discovers, develops and commercializes therapeutic strategies to treat debilitating inflammation, fibrosis and pain. The company develops drug candidates from several chemical classes that concentrates on the receptors and shows poten …
  • Electricidade de Mocambique EP:電力:M&Aディール及び事業提携情報
    Summary Electricidade de Mocambique EP (EDM) is a state owned vertically integrated energy utility that generates, distributes, transmits, and commercializes electricity. It produces electricity from hydro and thermal sources. The company has interests in Lichinga, Cuamba, Corumana, Chicamba, and Ma …
  • Medical Information Technology, Inc.-医療機器分野:企業M&A・提携分析
    Summary Medical Information Technology, Inc. doing business as Meditech, is a healthcare information technology solutions provider. The company develops, manufactures, licenses and supports computer software products for hospital market. Its software solution supports the complete spectrum of health …
  • Fuji Chemical Industry Co Ltd:戦略・SWOT・企業財務分析
    Fuji Chemical Industry Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Fuji Chemical Industry Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • T2 Biosystems Inc (TTOO):企業の製品パイプライン分析2018
    Summary T2 Biosystems Inc (T2 Biosystems) is a provider of clinical diagnostic products in the field of in vitro diagnostics. The company’s T2 magnetic resonance technology allows direct detection in complex samples such as whole blood, serum, plasma, sputum and urine. It offers T2HemoStat panel, T2 …
  • Phillips-Medisize LLC:企業の戦略的SWOT分析
    Phillips-Medisize LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • iCubate Inc:企業の製品パイプライン分析
    Summary iCubate Inc (iCubate) is a molecular diagnostic company that provides molecular diagnostic and in vitro diagnostic testing devices for syndromic testing. It develops cassettes and assays. The company’s pipeline products include flu typing cassette; HAI cassette; and STD cassette. iCubate uti …
  • Deutsche Telekom AG:戦略・SWOT・企業財務分析
    Deutsche Telekom AG - Strategy, SWOT and Corporate Finance Report Summary Deutsche Telekom AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Botswana Power Corporation:発電所・企業SWOT分析
    Botswana Power Corporation – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key em …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆